HealthUnlocked

Redirect Notice

Looks like you clickedhttps://www.urotoday.com/conference-highlights/esmo-2020/prostate-cancer/124493-esmo-virtual-congress-2020-phase-1b-2-study-of-veru-111-novel-oral-tubulin-inhibitor-in-men-with-metastatic-castration-resistant-prostate-cancer-who-failed-an-androgen-blocking-agent.html?utm_source=newsletter_8268&utm_medium=email&utm_campaign=draft-for-approval-identifying-metastatic-risk-in-men-with-nmcrpc-and-sequences-of-lines-of-therapy-in-mcrpc-and-other-data-from-day-one-of-the-esmo-virtual-congress-2020&goal=0_bc8795358a-44f1d66d33-199183633&mc_cid=44f1d66d33&mc_eid=ea308aeb36

If you do not want to visit that page, you can close this browser tab.